Publicatielijst

THE PURPOSE OF RESEARCH IS TO INCREASE OUR INSIGHT IN FUNCTION AND DYSFUNCTION OF THE VISUAL SYSTEM

Filter

B
C
D
F
L
M
R
S
V
W
- All

BALI Ernesto

1.De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-5

2.Bali E., Huyghe P., Caspers L. and Libert J. (2003). Vitrectomy and silicone oil in the treatment of acute endophthalmitis. Bull. Soc. belge Ophtalmol. 288, 9-14

3.Bali E., Willermain F., Caspers-Velu L., Dubois C., Dehou M.F., Velu T., Libert J. and Bruyns C. (2003). IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Int. J. Mol. Med. 12 (3), 305-310

BOUSSERY Koen

1.Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560

2.Van de Voorde J., Boussery K. and Vanheel B. (2001). Role of the endothelium in the vasorelaxing effect of histamine on rat isolated gastric small arteries. Inflamm. Res. 50 (Suppl. 2), S120-121

3.Boussery K., Franki A.S., Delaey C. and Van de Voorde J. (2002). A vasorelaxing factor is released form mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177

4.Mitamura M., Boussery K., Horie S., Murayama T. and Van de Voorde J. (2002). Vasorelaxing effect of mesaconitine, an alkaloid from Aconitum japonicum, on rat small gastric artery: possible involvement of endothelium-derived hyperpolarizing factor. Jpn. J. Pharmacol. 89 (4), 380-387

5.Boussery K., Delaey C. and Van de Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286

6.Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248

7.De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2003). Potassium potently relaxes small rat skeletal muscle arteries. Med. Sci. Sports Exerc. 35 (12), 2005-2012

8.Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559

9.De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2005). Hyperosmolarity increase K+-induced vasodilations in rat skeletal muscle arterioles. Med. Sci. Sports Exerc. 37 (2), 220-226

10.Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427

11.Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146

12.Peeters L., Sanders N.N., Braeckmans K., Boussery K., Van de Voorde J., De Smedt S.C. and Demeester J. (2005). Vitreous: a barrier to non-viral ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 46 (10), 3553-3561

CABAY Laurence

1.Cabay J.E., Boverie J.H. and Dondelinger R.F. (1998). Percutaneous catheter drainage of external fistulas of the pancreatic ducts. Eur. Radiol. 8 (3), 445-8

2.Cabay L., Willermain F., Bruyns C., Verdebout J.M., Witta Y., Baffi J., Velu T., Libert J., Caspers-Velu L., Maho A. and Lespagnard L. (2003). CXCR4 expression in vitreoretinal membranes. Br. J. Ophthalmol. 87 (5), 567-569

CLAERHOUT Ilse

1.Claerhout I. and Kestelyn P. (1999). Acanthamoeba keratitis: a review. Bull. Soc. belge Ophtalmol. 274, 71-82

2.Beele H., Claerhout I., Kestelyn P., Dierckxens L., Nayaert J.M. and De Laey J.J. (2001). Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatol. 202 (2), 147-150

3.Claerhout I., Beele H., Verstraete A., Van den Broecke C. and Kestelyn P. (2001). The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2), 152-157

4.Claerhout I., Beele H., Van den Abeele K. and Kestelyn P. (2002). Therapeutic penetrating keratoplasty: clinical outcome and evolution of endothelial cell denstity. Cornea. 21 (7), 637-642

5.Boonstra F., Claerhout I., Hol F., Smit G., van Collenburg V. and Meire F. (2002). Corneal decompensation in a boy with Kearns-Sayre syndrome. Ophthalmic Genet. 87 (5), 247-251

6.Sinnaeve B.A., Decaestecker T.N., Claerhout I.J., Kestelyn P., Remon J.P. and Van Bocxlaer J.F. (2003). Confirmation of ofloxacin precipitation in corneal deposits by microbore liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. J. Chromatogr. B. Analyt. Biomed. Life Sci. 785 (1), 193-196

7.Claerhout I. (2003). Corneal opacification following keratoplasty in the rat model. Br. J. Ophthalmol. 87 (2), 249-250

8.Claerhout I., Kestelyn P., Meire F., Remon J.P., Decaestecker T. and Van Bocxlaer J. (2003). Corneal deposits after the topical use of ofloxacin in two children with vernal keratoconjunctivitis. Br. J. Ophthalmol. 87 (5), 646

9.Claerhout I., Beele H., De Bacquer D. and Kestelyn P. (2003). Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 44 (11), 4747-4752

10.Goegebuer A., Ajay L., Claerhout I. and Kestelyn P. (2003). Results of penetrating keratoplasty in syphilitic interstitial keratitis. Bull. Soc. belge Ophtalmol. 290, 35-39

11.Claerhout I., Kestelyn P., Debacker V., Beele H. and Leclercq G. (2004). Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation. 77 (5), 676-682

12.Claerhout I., Goegebuer A., Van Den Broecke C. and Kestelyn P. (2004). Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch. Clin. Exp. Ophthalmol. 242 (8), 648-653

13.Claerhout I. and Kestelyn P. (2004). Results of penetrating keratoplasty in syphilitic interstitial keratitis (French). Rev. belge Med. Dent. 59 (1), 34-42

CLAES Catherine

1.De Graeve C., Van de Sompel W. and Claes C. (1999). Ocular ischemic syndrome: two case reports of bilateral involvement. Bull. Soc. belge Ophtalmol. 273, 69-74

2.Dorchy H., Claes C. and Verougstraete C. (2002). Risk Factors of Developing Proliferative Retinopathy in Type 1 Diabetic Patients: Role of BMI. Diabetes Care. 4, 798-799

3.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797

4.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193

5.Geerts L., Pertile G., Van de Sompel W., Moreels T. and Claes C. (2004). Vitrectomy for epiretinal membranes: visual outcome and prognostic criteria. Bull. Soc. belge Ophtalmol. 293, 7-15

6.Demols P., Claes C.A., Farber C.M. and Rasquin F. (2004). Macular CMV retinitis: a case report. Bull. Soc. belge Ophtalmol. 293, 17-21

COOLS Doris

1.Cools D., Debiec-Rychter M., Parys-Van Ginderdeuren R., Hagemeijer-Hausman A., Van den Oord J. and Spileers W. (2000). Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Bull. Soc. belge Ophtalmol. 278, 67-70

DE BAERE Elvire

1.De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of the cellular retinol-binding protein 1 gene (RBP1) and of the coatomer beta subunit gene (COPB2) to human chromosome band 3q23 by in situhybridization. Cytogenet. Cell. Genet. 82 (3-4), 226-227

2.De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of SHOX2 (alias OG12X and SHOT) to human chromosome bands 3q25-q26.1 by in situ hybridization. Cytogenet. Cell. Genet. 82 (3-4), 228-229

3.De Baere E., Van Roy N., Speleman F., Fukushima Y., De Paepe A. and Messiaen L. (1999). Closing in on the BPES gene on 3q2- mapping of a de novo reciprocal translocation t(3;4)(q23;p15.2) breakpoint within a 45-kb cosmid and mapping of three candidate genes, RBP1, RBP2 and beta’-COP, distal to the breakpoint. Genomics. 57 (1), 70-78

4.De Baere E., Fukushima Y., Small K., Udar N., Van Camp G., Verhoeven K., Palotie A., De Paepe A. and Messiaen L. (2000). Identification of BPESC1, a novel gene disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES. Genomics. 68 (3), 296-304

5.Gross C., De Baere E., Lo A., Chang W. and Messiaen L. (2001). Cloning and characterization of human WDR10, a novel gene located at 3q21 encoding a WD-repeat protein that is highly expressed in pituitary and testis. DNA Cell Biol. 20 (1), 41-52

6.De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L., Courtens W., Hjalgrim H., Huang S., Liebaers I., Van Regemorter N., Touraine P., Praphanphoj V., Verloes A., Udar N., Yellore V., Chalukya M., Yelchits S., De Paepe A., Kuttenn F., Fellous M., Veitia R. and Messiaen L. (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Molec. Genet. 10 (15), 1591-1600

7.De Baere E., Lemercier B., Christin-Maitre S., Durval D., Messiaen L., Fellous M. and Veitia R. (2002). FOXL2 mutation screening in a large panel of POF patients and XX males. J. Med. Genet. 39 (8), 43

8.Cocquet J., Pailhoux E., Jaubert F., Servel N., Xia X., Pannetier M., De Baere E., Messiaen L., Cotinot C., Fellous M. and Veitia R. (2002). Evolution and expression of FOXL2. J. Med. Genet. 39 (12), 916-921

9.De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R. and Messiaen L. (2003). FOXL2 and BPES: mutational hotspots, phenotypic variability and revision of the genotype-phenotype correlation. Am. J. Hum. Genet. 72 (2), 478-487

10.Cocquet J., De Baere E., Caburet S. and Veitia R. (2003). Compositional biases and polyalanine runs in humans. Genetics. 165 (3), 1613-1617

11.Cocquet J., De Baere E., Gareil M., Pannetier M., Xia X., Fellous M. and Veitia R.A. (2003). Structure, evolution and expression of the FOXL2 transcription unit (review). Cytogenet. Genome Res. 101 (3-4), 206-211

12.Beysen D., Vandesompele J., Messiaen L., De Paepe A. and De Baere E. (2004). The human FOXL2 mutation database. Hum. Mutat. 24 (3), 189-193

13.Caburet S., Demarez A., Moumne L., Fellous M., De Baere E. and Veitia R.A. (2004). A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J. Med. Genet. 41 (12), 932-936

14.Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., Fryns J.P., Kim J.R., Lapunzina P., Lemyre E., Meire F., Messiaen L.M., Oley C., Splitt M., Thomson J., Peer Y.V., Veitia R.A., De Paepe A. and De Baere E. (2005). Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharochimosis syndrome. Am. J. Hum. Genet. 77 (2), 205-218

DE JONG Casper

1.De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-75

DE KEYZER Katrien

1.De Keyzer K. and Tassignon M.J. (2004). Case report: acute unilateral loss of visual acuity after a visit to the dentist: an unusual complication after the use of an anesthetic combined with adrenaline (French). Rev. belge Med. Dent. 59 (1), 30-33

DELAEY Christophe

1.Delaey C. and Van de Voorde J. (1995). Prostanoid-induced contractions are blocked by sulfonylureas. Eur. J. Pharmacol. 280 (2), 179-184

2.Delaey C. and Van de Voorde J. (1997). Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. Eur. J. Pharmacol. 325 (1), 41-46

3.Van de Voorde J., Delaey C, Depypere H. and Vanheel B. (1998). Mechanisms involved in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Eur. J. Pharmacol. 349 (1), 61-66

4.Delaey C. and Van de Voorde J. (1998). The effect of NO donors on bovine retinal small arteries and posterior ciliary arteries. Invest. Ophthalmol. Vis. Sci. 39 (9), 1642-1646

5.Delaey C. and Van de Voorde J. (1998). Retinal arterial tone is controlled by a retinal-derived relaxing factor. Circ. Res. 83 (7), 714-720

6.Van de Voorde J., Delaey C., Depypere H. and Vanheel B. (1999). Role of the endothelium in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Inflamm. Res. 48 (Suppl. 1), S100-101

7.Delaey C. and Van de Voorde J. (2000). Pressure-induced myogenic responses in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (7), 1871-1875

8.Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560

9.Delaey C. and Van De Voorde J. (2000). Regulatory mechanisms in the retinal and choroidal circulation (review). Ophthalmic Res. 32 (6), 249-256

10.Delaey C. (2001). Retinal tissue modulates retinal arterial tone through the release of a potent vasodilating factor. Verh. K. Acad. Geneeskd. Belg. 63 (4), 335-357

11.Boussery K., Franki A.S., Delaey C. and Van De Voorde J. (2002). A vasorelaxing factor is released from mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177

12.Boussery K., Delaey C. and Van De Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286

13.Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248

14.Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559

15.Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427

16.Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146

DENYS Katrien

1.Vanduffel W., Fize D., Peuskens H., Denys K., Sunaert S., Todd J.T. and Orban G.A. (2002). Extracting 3D from motion: differences in human and monkey intraparietal cortex. Science. 298 (5592), 413-415

2.Fize D., Vanduffel W., Nelissen K., Denys K., Chef d’Hotel C., Faugeras O. and Orban G.A. (2003). The retinotopic organization of primate dorsal V4 and surrounding areas: a functional magnetic resonance imaging study in awake monkeys. J. Neurosci. 23 (19), 7395-7406

3.Orban G.A., Fize D., Peuskens H., Denys K., Nelissen K., Sunaert S., Todd J. and Vanduffel W. (2003). Similarities and differences in motion processing between the human and macaque brain: evidence from fMRI. Neuropsychologia 41 (13), 1757-1768

4.Denys K., Vanduffel W., Fize D., Nelissen K., Peuskens H., Van Essen D. and Orban G.A. (2004). The processing of visual shape in the cerebral cortex of human and non-human primates: a functional magnetic resonance imaging study. J. Neurosci. 24 (10), 2551-2565

5.Denys K., Vanduffel W., Fize D., Nelissen K., Sawamura H., Georgieva S., Vogels R., Van Essen D. and Orban G.A. (2004). Visual activation in prefrontal cortex is stronger in monkeys than in humans. J. Cogn. Neurosci. 16 (9), 1505-1516

DILLEN Kathleen

1.Dillen K., Vandervoort J., Van den Mooter G., Verheyden L. and Ludwig A. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm. 275 (1-2), 171-187

2.Dillen K., Weyenberg W., Vandervoort J. and Ludwig A. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur. J. Pharm. Biopharm. 58 (3), 539-549

3.Dillen K., Vandervoort J. and Ludwig A. (2005). Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use. J. Control Release 101 (1-3), 369-371

4.Bozdag S., Dillen K., Vandervoort J. and Ludwig A. (2005). The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. J. Pharm. Pharmacol. 57 (6), 699-707

DUCHESNE Bernard

1.Comhaire-Poutchinian Y., Duchesne B. and Ries M. (1993). The value of MRI in a difficult diagnosis of melanoma of the choroid (French). Bull. Soc. belge Ophtalmol. 248, 47-51

2.Marechal-Courtois C. and Duchesne B. (1993). Recurrent corneal erosion (French). Bull. Soc. belge Ophtalmol. 247 (1), 13-15

3.Duchesne B. (1993). HLA typing and corneal grafts (French). Bull. Soc. belge Ophtalmol. 247 (1), 29-32

4.Duchesne B., Marechal-Courtois C. and Melin P. (1994). A case of keratitis due to Mycobacterium chelonae (French) (review). Bull. Soc. belge Ophtalmol. 254, 59-62

5.Locht B., Janssens M., Duchesne B. and Bonnet S. (1995). Normovolemic hemodilution in central retinal vein thrombosis: personal experience apropos of 14 cases (French). Bull. Soc. belge Ophthalmol. 259, 89-92

6.Comhaire-Poutchinian Y., Duchesne B., Collignon J., Ries M. (1996). Magnetic resonance imaging in the diagnosis of doubtful cases of small melanoma of the choroid (French). J. Fr. Ophtalmol. 19 (2), 111-119

7.Joachim M., Andris C., Duchesne B. (1996). Pharma-clinics. How I treat … thyroid ophthalmopathy (French). Rev. Med. Liège. 51 (7), 449-452

8.Tahi H., Kondo H., Duchesne B., Lee W., Feuer W. and Parel J.M. (1998). Gel injection adjustable keratoplasty (GIAK): keratometric evaluation on cadaver eyes (French). Bull. Soc. belge Ophtalmol. 268, 13-17

9.Duchesne B., Tahi H., Gautier S., Jallet V., Villain F., Parel J.M. (1998). Implantation of controlled-release 5-FU for the prevention of secondary cataract: preliminary study (French). Bull. Soc. belge Ophtalmol. 268, 69-72

10.Duchesne B., Mans B., Lavalley B., Gerard C., Marechal-Courtois C., Betz P. and Tseng S.C. (1998). Use of the cryopreserved human amniotic membrane for reconstruction of the ocular surface (French). Bull. Soc. belge Ophtalmol. 268, 73-77

11.Claes E., Duchesne B., Lavalleye B., Lejeune T., Delcourt J.C., Bouillenne C. and Marechal-Courtois C. (1998). Types of corneal transplantation: experience and review (French). Bull. Soc. belge Ophtalmol. 268, 87-92

12.Tahi H., Duchesne B., Parel J.M., Nose I., Denham D., Villain F. and Lacombe E. (1998). Keratoprosthesis by posterior fixation and mechanical biocompatibility: determination of intraocular pressure provoking aqueous humor leak and/or extrusion (French). Bull. Soc. belge Ophtalmol. 268, 87-92

13.Carrette S., Marechal-Courtois C., Hernandez J., Hayette M.P., Deprez M. and Duchesne B. (2000). Report of a case of Acanthamoeba keratitis (French). Bull. Soc. belge Ophtalmol. 275, 49-53

14.Duchesne B., Tahi H. and Galand A. (2001). Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea. 20 (2), 230-232

15.Hamaoui M., Tahi H., Chapon P., Duchesne B., Fantes F., Feuer W. and Parel J.M. (2001). Corneal preparation of eye bank eyes for experimental surgery. Cornea. 20 (3), 317-320

16.Hick S., Duchesne B., Kaye O., Marechal-Courtois C. and Galand A. (2002). Corneal ulcers associated with rheumatoid arthritis (French). Rev. Med. Liège. 57 (4), 228-232

17.Barile P., Leroy C., Bolle S., Arrese J.E., Hermanns-Le T., Pierard G.E. and Duchesne B. (2004). Merkel cell carcinoma (French). J. Fr. Ophtalmol. 27 (4), 432-436

18.Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890

19.Hick S., Demers P.E., Brunette I., La C., Mabon M. and Duchesne B. (2005). Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 24 (4), 369-377

FOLLENS Ingrid

1.Van Overmeire B., Follens I., Hartmann S., Creten W.L. and Van Acker K.J. (1997). Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child Fetal Neonatal Ed. 76 (3), F179-184

2.Follens I., Godts D., Evens P.A. and Tassignon M.J. (2001). Combined fourth and sixth cranial nerve palsy after lumbar puncture: a rare complication. A case report. Bull. Soc. belge Ophtalmol. 281, 29-33

3.Van Kerckhoven W., Lafaut B., Follens I. and De Laey J.J. (2001). Features of age-related macular degeneration on optical coherence tomography. Bull. Soc. belge Ophtalmol. 281, 75-84

LAFAUT Bart

1.Lafaut B.A., Sallet G. and De Laey J.J. (1993). Hypofluorescence in infrared angiography. Bull. Soc. belge Ophtalmol. 250, 45-50

2.Lafaut B.A., Hanssens M., Verbraeken H. and De Laey J.J. (1994). Chorioretinal biopsy in the diagnosis of intraocular lymphoma: a case report. Bull. Soc. belge Ophtalmol. 252, 67-73

3.Lafaut B.A., Bourgoignie K.B., Sallet G. and De Laey J.J. (1994). Diffuse bilateral proliferation of uveal melanocytes. Apropos of an uncommon case (French) (review). J. Fr. Ophtalmol. 17 (3), 208-213

4.Lafaut B.A., Sallet G. and De Laey J.J. (1995). Discrepancy between indocyanine green and fluorescein angiography in occult choroidal neovascularisation. Bull. Soc. belge Ophtalmol. 255, 69-77

5.Lafaut B.A., Vianna R.N., De Baets F. and Meire F. (1995). Unilateral cytomegalovirus retinitis in a patient with immunoglobulin G2 deficiency. Ophthalmologica. 209 (1), 40-43

6.Lafaut B.A., van Egmond J. and De Laey J.J. (1995/1996). Asymmetric fundus flavimaculatus/Stargardt’s disease, associated with unilateral myopia. Int. Ophthalmol. 19 (4), 253-255

7.Amoaku W.M., Lafaut B., Sallet G. and De Laey J.J. (1995). Radiation choroidal vasculopathy: an indocyanine green angiography study. Eye. 9 (Pt. 6), 738-744

8.Sallet G., Amoaku W.M., Lafaut B.A., Brabant P. and De Laey J.J. (1995). Indocyanine green angiography of choroidal tumors. Graefes Arch. Clin. Exp. Ophthalmol. 233 (11), 677-689

9.Sallet G., Lafaut B.A. and De Laey J.J. (1996). Indocyanine green angiography and age-related serous pigment epithelial detachment. Graefes Arch. Clin. Exp. Ophthalmol. 234 (1), 25-33

10.Lafaut B.A., Priem H. and De Laey J.J. (1996). Premacular fibrosis in juvenile Coats’ disease with spontaneous peeling after photocoagulation of the congenital vascular anomalies. Bull. Soc. belge Ophtalmol. 261, 79-84

11.Verbraeken H.E., Hanssens M., Priem H., Lafaut B.A. and De Laey J.J. (1997). Ocular non-Hodgkin’s lymphoma: a clinical study of nine cases. Br. J. Ophthalmol. 81 (1), 31-36

12.Lafaut B.A., Mestdagh C., Kohno T., Gaudric A. and De Laey J.J. (1997). Indocyanine green angiography in choroidal osteoma. Graefes Arch. Clin. Exp. Ophthalmol. 235 (5), 330-337

13.Lafaut B.A. and De Laey J.J. (1996). Indocyanine green angiography in central serous chorioretinopathy. Bull. Soc. belge Ophthalmol. 262, 55-61

14.Lafaut B.A., Hanssens M., Verbraeken H. and De Laey J.J. (1996). Clinicopathologic correlation in a case of metastatic uveal tumor. Bull. Soc. belge Ophtalmol. 263, 27-37

15.Sallet G., Amoaku W.M., Lafaut B.A., Van Liefferinge B. and De Laey J.J. (1996). Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106. Bull. Soc. belge Ophtalmol. 263, 27-37

16.Lafaut B.A., De Vriese A.S. and Stulting A.A. (1997). Fundus fluorescein angiography of patients with severe hypertensive nephropathy. Graefes Arch. Clin. Exp. Ophthalmol. 235 (12), 749-754

17.Lafaut B.A., Priem H. and De Laey J.J. (1997). Indocyanine green angiography in angioid streaks. Bull. Soc. belge Ophtalmol. 265, 21-24

18.Salati C., Pantelis V., Lafaut B.A., Sallet G. and De Laey J.J. (1997). A 8 months indocyanine angiographic follow-up of a patient with serpiginous choroidopathy. Bull. Soc. belge Ophtalmol. 265, 29-33

19.Salati C., Lafaut B.A., Stevens A., De Laey J.J. and Kestelyn P. (1998). Indocyanine green angiography in a case of Bietti’s disease. Retina. 18 (1), 82-84

20.Lafaut B.A., Leys A.M., Scassellati-Sforzolini B., Priem H. and De Laey J.J. (1998). Comparison of fluorescein and indocyanine green angiography in angioid streaks. Graefes Arch. Clin. Exp. Ophthalmol. 236 (5), 346-353

21.Lafaut B.A., Salati C., Priem H. and De Laey J.J. (1998). Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch. Clin. Exp. Ophthalmol. 236 (7), 513-521

22.Verhaeghe I., Lafaut B.A., Brandt A., De Laey J.J. (1997). Retinal capillary hemangioma: von Hippel(-Lindau) disease. Bull. Soc. belge Ophtalmol. 267, 91-97

23.Meire F.M., Lafaut B.A., Speleman F. and Hanssens M. (1998). Isolated Norrie disease in a female caused by a balanced translocation t(X,6). Ophthalmic Genet. 19 (4), 203-207

24.Schelfhout V., Lafaut B., Van den Neste C., Kestelyn P. and De Laey J.J. (1998). Multiple evanescent white dot syndrome. Bull. Soc. belge Ophtalmol. 270, 19-23

25.Giovannini A., Scassellati-Sforzlini B., Lafaut B., Edeling J., D’Altobrando E. and De Laey J.J. (1999). Indocyanine green angiography of retinal pigment epithelial tears. Acta Ophthalmol. Scand. 77 (1), 83-87

26.De Meyer V., Lafaut B.A., Van de Sompel W. and De Laey J.J. (1999). Multifocal choroiditis with panuveitis and punctate inner choroidopathy: a mini review. Bull. Soc. belge Ophtalmol. 273, 115-124

27.Lafaut B.A., Meire F.M., Leys A.M., Dralands G. and De Laey J.J. (1999). Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch. Clin. Exp. Ophthalmol. 237 (12), 1033-1038

28.Lafaut B.A., Bartz-Schmidt K.U., Vanden Broecke C., Aisenbrey S., De Laey J.J. and Heimann K. (2000). Clinicopathological correlation in exudative age-related macular degeneration: histological differentiation between classical and occult choroidal neovascularisation. Br. J. Ophthalmol. 84 (3), 239-243

29.Lafaut B.A., De Backer E., Kohno T., De Laey J.J. and Meire F.M. (2000). Indocyanine green angiography in Sorsby’s fundus dystrophy. Graefes Arch. Clin. Exp. Ophthalmol. 238 (2), 158-162

30.Thumann G., Aisenbrey S., Schaermeyer U., Lafaut B., Esser P., Walter P. and Bartz-Schmidt K.U. (2000). Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch. Ophthalmol. 118 (10), 1350-1355

31.Cursiefen C., Holbach L.M., Lafaut B., Heimann K., Kirchner T. and Naumann G.O. (2000). Oculocerebral non-Hodgkin’s lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch. Ophthalmol. 118 (10), 1437-1440

32.Lafaut B.A., Leys A.M., Snyers B., Rasquin F. and De Laey J.J. (2000). Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch. Clin. Exp. Ophthalmol. 238 (9), 752-759

33.Lafaut B.A., Aisenbrey S., Vanden Broecke C. and Bartz-Schmidt K.U. (2000). Clinicopathological correlation of deep retinal vascular anomalous complex in age-related macular degeneration. Br. J. Ophthalmol. 84 (11), 1269-1274

34.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Bartz-Schmidt K.U. and Heimann K. (2000). Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina. 20 (6), 650-654

35.Szurman P., Di Tizio F.M., Lafaut B., Aisenbrey S., Grisanti S., Roters S. and Bartz-Schmidt K.U. (2000). Significance of postoperative face-down positioning after surgery for idiopathic macular holes: consecutive case-control study (German). Klin. Monatsbl. Augenheilkd. 217 (6), 351-355

36.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Krott R., Jonescu-Cuypers C.P., Reynders S., Bartz-Schmidt K.U. (2001). Clinicopathological correlation of retinal pigment epithelial tears in exudative age-related macular degeneration: pretear, tear and scarred tear. Br. J. Ophthalmol. 85 (4), 454-460

37.Lafaut B.A., Aisenbrey S., Vanden Broecke C., Di Tizio F. and Bartz-Schmidt K.U. (2001). Clinicopathological correlation in exudative age-related macular degeneration: recurrent choroidal neovascularisation (review). Graefes Arch. Clin. Exp. Ophthalmol. 239 (1), 5-11

38.Lafaut B.A., Loeys B., Leroy B.P., Spileers W., De Laey J.J. and Kestelyn P. (2001). Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree. Graefes Arch. Clin. Exp. Ophthalmol. 239 (8), 575-582

39.Lafaut B.A. (2000). Clinicopathologic correlation of surgically removed submacular tissue. Bull. Soc. belge Ophtalmol. 278, 49-53

40.Aisenbrey S., Lafaut B., Szurman P., Grisanti S., Fricke J., Neugebauer A., Hilgers R.D., Esser P., Walter P. and Bartz-Schmidt K.U. (2002). Macular translocation with 360 degree retinotomy in the treatment if exudative macular degeneration. Functional and angiographic results (German). Der Ophthalmologe. 99 (3), 164-170

41.Aisenbrey S., Lafaut B.A., Szurman P., Grisanti S., Luke C., Krott R., Thumann G., Fricke J., Neugebauer A., Hilgers R.D., Esser P., Walter P. and Bartz-Scmidt K.U. (2002). Macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration. Arch. Ophthalmol. 120 (4), 451-459

42.Lafaut B.A., Mietz H., Ortmann M. and Bartz-Schmidt K.U. (2002). Melanocytoma of the choroid: angiographic and histopathologic findings. Ophthalmic Surg. Lasers. 33 (2), 158-162

43.Reynders S., Lafaut B.A., Aisenbrey S., Vanden Broecke C., Lucke K., Walter P., Kirchhof B. and Bartz-Schmidt K.U. (2002). Clinicopathologic correlation in hemorrhagic age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 240 (4), 279-285

44.Kutchoukov B., Lafaut B. and De Laey J.J. (2002). Three-dimensional posterior segment ultrasonography: clinical experience. Bull. Soc. belge Ophtalmol. 283, 51-57

45.Aisenbrey S., Lafaut B.A., Reynders S., Szurman P., Grisanti S., Vanden Broecke C., Walter P. and Bartz-Schmidt K.U. (2003). Clinicopathological correlation of choroidal neovascularisation after external beam radiotherapy in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 241 (4), 269-276

46.Hayami M., Decock C., Brabant P., Van Kerckhoven W., Lafaut B.A. and De Laey J.J. (2003). Optical coherence tomography of adult-onset vitelliform dystrophy. Bull. Soc. belge Ophtalmol. 289, 53-61

47.Grisanti S., Canbek S., Kaiserling E., Adam A., Lafaut B., Gelisken F., Szurman P., Henke-Fahle S., Oficjalska-Mlynczak J. and Bartz-Schmidt K.U. (2004). Expression of endoglin in choroidal neovascularisation. Exp. Eye Res. 78 (2), 207-213

48.Gelisken F., Lafaut B.A., Inhoffen W., Voelker M., Grisanti S. and Bartz-Schmidt K.U. (2004). Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy. Br. J. Ophthalmol. 88 (2), 207-213

49.Grisenti S., Tatar O., Canbek S., Lafaut B.A., Gelisken F., Inhoffen W., Szurman P., Aisenbrey S., Oficjalska-Mlynczak J., Bartz-Schmidt K.U. (2004). Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy. Am. J. Ophthalmol. 137 (5), 914-923

50.Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B., Messiaen L.M., Perveen R, Reddy M.A., Bhattacharya S.S., Traboulsi E., Baralle D., De Laey J.J., Puech B., Kestelyn P., Moore A.T., Manson F.D. and Black G.C. (2004). Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest. Ophthalmol. Vis. Sci. 45 (10), 3683-3689

LAMBERT Vincent

1.Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M. and Rakic J.M. (2002). Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am. J. Pathol. 161 (4), 1247-1253

2.Rakic J.M., Lambert V., Munaut C., Bajou K., Peyrollier K., Alvarez-Gonzalez M.L., Carmeliet P., Foidart J.M. and Noel A. (2003). Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (4), 1732-1739

3.Rakic J.M., Lambert V., Deprez M., Foidart J.M., Noel A. and Munaut C. (2003). Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest. Ophthalmol. Vis. Sci. 44 (4), 1740-1746

4.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797

5.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193

6.Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A. and Rakic J.M. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularisation. FASEB J. 17 (15), 2290-2220

LEROY Bart

1.Messiaen L., Leroy B.P., De Bie S., De Pauw K., Van Roy N., Speleman F., Van Camp G. and De Paepe A. (1996). Refined genetic and physical mapping of BPES type II. Eur. J. Hum. Genet. 4 (1), 34-38

2.Leroy B.P., Carton D. and De Laey J.J. (1996). Ophthalmological signs of tuberous sclerosis. Bull. Soc. belge Ophtalmol. 262, 115-121

3.Uvijls A., Leroy B.P., Leys M., De Rouck A. and Kestelyn P. (1998). A large field panel D-15 test for low vision patients. Bull. Soc. belge Ophtalmol. 270, 57-65

4.Schocki M.M., Perrault I., Leroy B.P., Payne A.M., Dharmaraj S., Bhattacharya S.S., Kaplan J., Maumenee I.H., Koenekoop R., Meire F.M., Birch D.G., Heckenlively J.R. and Daiger S.P. (2000). Prevalence of AIPL1 mutations in inherited retinal degenerative disease. Mol. Genet. Metab. 70 (2), 142-150

5.Lehmann O.J., Ebenezer N.D., Jordan T., Fox M., Ocaka L., Payne A., Leroy B.P., Clark B.J., Hitchings R.A., Povey S., Khaw P.T. and Bhattacharya S.S. (2000). Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am. J. Hum. Genet. 67 (5), 1129-1135

6.Khaliq S., Hameed A., Ismail M., Anwar K., Leroy B.P., Mehdi S.Q., Payne A.M. and Bhattacharya S.S. (2000). Novel locus for autosomal recessive cone-rod dystrophy CORD8 mapping to chromosome 1q12-q24

7.Payne A., Vithana E., Khaliq S., Hameed A., Deller J., Abu-Safieh L., Kermani S., Leroy B.P., Mehdi S.Q., Moore A.T., Bird A.C. and Bhattacharya S.S. (2000). RP1 protein truncating mutations predominate at the RP1 adRP locus. Invest. Ophthalmol. Vis. Sci. 41 (13), 4069-4073

8.Leroy B.P., Aragon-Martin J.A., Weston M.D., Bessant D.A., Willis C., Webster A.R., Bird A.C., Kimberling W.J., Payne A.M. and Bhattacharya S.S. (2001). Spectrum of mutations in USU2A in British patients with Usher syndrome type II. Exp. Eye Res. 72 (5), 503-509

9.De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L., Courtens W., Hjalgrim H., Huang S., Liebaers I., Van Regemorter N., Touraine P., Praphanphoj V., Verloes A., Udar N., Yellore V., Chalukya M., Yelchits S., De Paepe A., Kuttenn F., Fellous M., Veitia R. and Messiaen L. (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Mol. Genet. 10 (15), 1591-1600

10.De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R. and Messiaen L. (2003). FOXL2 and BPES: mutation hotspots, phenotypic variability and revision of the genotype-phenotype correlation. Am. J. Hum. Genet. 72 (2), 478-487

11.Blaydon D.C., Mueller R.F., Hutchin T.P., Leroy B.P., Bhattacharya S.S., Bird A.C., Malcolm S. and Bitner-Glindzicz M. (2003). The contribution of USH1C mutations and non-syndromic deafness in the UK. Clin. Genet. 63 (4), 303-307

12.Dharmaraj S., Leroy B.P., Sohocki M.M., Koenekoop R.K., Perrault I., Anwar K., Khaliq S., Devi R.S., Birch D.G., De Pool E., Izquierdo N., Van Maldergem L., Ismail M., Paine A.M., Holder G.E., Bhattacharya S.S., Bird A.C., Kaplan J., Maumenee I.H. (2004). The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations. Arch. Ophthalmol. 122 (7), 1029-1037

13.Yardley J., Leroy B.P., Hart-Holden N., Lafaut B.A., Loeys B., Messiaen L.M., Perveen R., Reddy M.A., Bhattacharya S.S., Traboulsi E., Baralle D., De Laey J.J., Puech B., Kestelyn P., Moore A.T., Manson F.D. and Black G.C. (2004). Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest. Ophthalmol. Vis. Sci. 45 (10), 3683-3689

14.Leroy J.G., Leroy B.P., Emmery L.V., Messiaen L. and Spranger J.W. (2004). A new type of autosomal recessive spondyloepiphyseal dysplasia tarda. Am. J. Med. Genet. 125A (1), 49-56

15.Witters J.A., De Zaeytijd J., Leys M. and Leroy B.P. (2004). Progressive cone dystrophy and sensorineural hearing loss. Bull. Soc. belge Ophtalmol. 294, 35-42

16.De Bleecker J.L., Leroy B.P. and Meire V.I. (2005). Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity. Eur. Neurol. 53 (2), 93-95

17.Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., Fryns J.P., Kim J.R., Lapunzina P., Lemyre E., Meire F., Messiaen L.M., Oley C., Splitt M., Thomson J., Peer Y.V., Veitia R.A., De Paepe A. and De Baere E. (2005). Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am. J. Hum. Genet. 77 (2), 205-218

MISSOTTEN Tom

1.Sifrim D., Holloway R.H., Tack J., Zelter A., Missotten T., Coulie B. and Janssens J. (1999). Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am. J. Gasteroenterol. 94 (11), 3158-3164

2.Vanschoubroek K., Missotten T. and Dralands L. (2001). Pitfalls in the diagnosis of craniopharyngioma: 2 case reports. Bull. Soc. belge Ophtalmol. 281, 41-47

3.Bremond-Gignac D., Tixier J., Missotten T., Laroche L. and Beresniak A. (2002). Evaluation of the quality of life in ophthalmology (French) (review). Presse Med. 31 (34), 1607-1612

4.Awotescu O., Missotten T., Pitcher M.C., Lynn W.A. and Lightman S. (2004). Uveitis in a patient receiving rifabutin for Crohn’s disease. J. R. Soc. Med. 97 (9), 440-441

5.Missotten T., Verhamme T., Blanckaert J. and Missotten G. (2004). Optical formula to predict outcomes after implantation of accommodating intraocular lenses. J. Cataract Refract. Surg. 30 (10), 2084-2087

RAKIC Jean-Marie

1.Rakic J.M. (1993). Cyclosporin in ophthalmology. Bull. Soc. belge Ophtalmol. 247 (1), 67-70

2.Rakic J.M., Galand A. and Vrensen G.F. (1997). Separation of fibres from the capsule enhances mitotic activity of human lens epithelium. Exp. Eye Res. 64 (1), 67-72

3.Wormstone I.M., Liu C.S., Rakic J.M., Marcantonio J.M., Vrensen G.F. and Duncan G. (1997). Human lens epithelial cell proliferation in a protein-free medium. Invest. Ophthalmol. Vis. Sci. 38 (2), 396-404

4.Van Cauwenberge F., Rakic J.M. and Galand A. (1997). Complicated posterior capsulorhexis: aetiology, management and outcome. Br. J. Ophthalmol. 81 (3), 195-198

5.Massoud H., Comhaire-Poutchinian Y. and Rakic J.M. (1997). Transvitreal endocryoapplication of the ciliary body (French). Bull. Soc. belge Ophtalmol. 267, 177-181

6.Rakic J.M., Galand A. and Vrensen G.F. (2000). Lens epithelial cell proliferation in human posterior capsule opacification specimens. Exp. Eye Res. 71 (5), 489-494

7.Marcantonio J.M., Rakic J.M., Vrensen G.F. and Duncan G. (2000). Lens cell populations studied in human donor capsular bags with implanted intraocular lenses. Invest. Ophthalmol. Vis. Sci. 41 (5), 1130-1141

8.Lambert V., Munaut C., Noel A., Frankenne F., Bajou K., Gerard R., Carmeliet P., Defresne M.P., Foidart J.M. and Rakic J.M. (2001). Influence of plasminogen activator inhibitor type 1 on choroidal neovascularisation. FASEB J. 15 (6), 1021-1027

9.Munaut C., Lambert V., Noel A., Frankenne F., Deprez M., Foidart J.M. and Rakic J.M. (2001). Presence of oestrogen receptor type beta in human retina. Br. J. Ophthalmol. 85 (7), 877-882

10.Lambert V., Munaut C., Jost M., Noel A., Werb Z., Foidart J.M. and Rakic J.M. (2002). Matrix metalloproteinase-9 contributes to choroidal neovascularisation. Am. J. Pathol. 161 (4), 1247-1253

11.Rakic J.M., Lambert V., Munaut C., Bajou K., Peyrollier K., Alvarez-Gonzalez M.L., Carmeliet P., Foidart J.M. and Noel A. (2003). Mice without uPA, tPA or plasminogen genes are resistant to experimental choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (4), 1732-1739

12.Rakic J.M., Lambert V., Deprez M., Foidart J.M., Noel A. and Munaut C. (2003). Estrogens reduce the expression of YKL-40 in the retina: implications for eye and joint diseases. Invest. Ophthalmol. Vis. Sci. 44 (4), 1740-1746

13.Rakic J.M., Maillard C., Jost M., Bajou K., Masson V., Devy L., Lambert V., Foidart J.M. and Noel A. (2003). Role of plasminogen activator-plasmin system in tumor angiogenesis (review). Cell. Mol. Life Sci. 60 (3), 463-473

14.Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797

15.Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193

16.Rakic J.M., Zelinkova M., Comhaire-Poutchinian Y., Galand A. and Duchateau E. (2003). Treatment of Graves macular edema with intravitreal injection of corticosteroids (French). Bull. Soc. belge Ophtalmol. 288, 43-48

17.Lambert V., Wielockx B., Munaut C., Galopin C., Jost M., Itoh T., Werb Z., Baker A., Libert C., Krell H.W., Foidart J.M., Noel A. and Rakic J.M. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularisation. FASEB J. 17 (15), 2290-2292

18.Rakic J.M. and Hermans G. (2004). Patient access to the medical file (French). Bull. Soc. belge Ophtalmol. 291, 47-50

19.Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890

20.Rakic J.M., Blaise P. and Foidart J.M. (2005). Pegaptanib and age-related macular degeneration. N. Engl. J. Med. 352 (16), 1720-1721

21.Xhauflaire G., Uhoda E. and Rakic J.M. (2005). Eye and ultraviolet light (French). Rev. Med. Liege. 60 Suppl. 1, 99-102

22.Blaise P., Comhaire Y. and Rakic J.M. (2005). Giant macular hole as an atypical consequence of a toxoplasmic chorioretinitis. Arch. Ophthalmol. 123 (6), 863-864

23.Blaise P., Duchateau E., Comhaire Y. and Rakic J.M. (2005). Improvement of visual acuity after photodynamic therapy for choroidal neovascularization in choroidal osteoma. Acta Ophthalmol. Scand. 83 (4), 515-516

24.Barile S., Van Cauwenberge F. and Rakic J.M. (2005). Diabetic retinopathy (French). Rev. Med. Liege. 60 (5-6), 487-489

ROBE-COLLIGNON Nathalie

1.Collignon-Brach J. and Robe-Collignon N. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. 276, 61-68

2.Collignon-Brach J.D., Ravet O. and Robe-Collignon N. (2000). Surgical indications in coexisting cataracts and glaucoma (French) (review). Bull. Soc. belge Ophtalmol. Suppl. 11-36

3.Robe-Collignon N.J. and Collignon-Brach J.D. (2000). Non perforating trabecular surgery with reticulated hyaluronic acid implant (French). Bull. Soc. belge Ophtalmol. Suppl. 45-54

4.Banks M.C., Robe-Collignon N.J., Rizzo J.F. 3rd and Pasquale L.R. (2003). Scanning laser polarimetry of edematous and atrophic optic nerve heads. Arch. Ophthalmol. 121 (4), 484-490

ROZEMA Jos

1.Rozema J.J., Van Dyck D.E.M. and Tassignon M.J. (2005). Clinical comparison of 5 aberrometers (I). Technical specifications. J. Cat. Refract. Surg. 31 (6), 1114-1127

2.Rozema J.J., Van Dyck D.E.M., Pauw M., Van Der Spek B. and Tassignon M.J. (submitted). Clinical comparison of 5 aberrometers (II). Statistical comparison on a test group. J. Cat. Refract. Surg.

STALMANS Ingeborg

1.Vanderschueren A., Stalmans I., Lombaerts R. and Leys A. (1996). Ocular abnormalities in patients with Alport’s syndrome. Nephrol. Dial. Transplant. 11 (11), 2355-2358

2.Stalmans I., Buys K., Leys A. and Dralands L. (1997). Spontaneous evolution of stage I and II macular holes. Bull. Soc. belge Ophtalmol. 267, 37-42

3.Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D’Amore P.A. and Shima D.T. (1999). Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5 (5), 495-502

4.Spiritus A., Dralands L., Stalmans P., Stalmans I. and Spileers W. (2000). OCT study of fellow eyes of macular holes. Bull. Soc. belge Ophtalmol. 275, 81-84

5.Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., Di Palma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K.H., Foidart J.M., Schaper W., Charnock-Jones D.S., Hicklin D.J., Herbert J.M., Collen D. and Persico M.G. (2001). Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7 (5), 575-583

6.Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., Hammes H.P., Moons L., Dewerchin M., Collen D., Carmeliet P. and D’Amora P.A. (2002). Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109 (3), 327-336

7.Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285

8.Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der Ohe M., Swillen A., Maes C., Gewillig M., Molin D.G., Hellings P., Boetel T., Haardt M., Compernolle V., Dewerchin M., Plaisance S., Vlietinck R., Emanuel B., Gittenberger-de Groot A.C., Scambler P., Morrow B., Driscol D.A., Moons L., Esguerra C.V., Carmeliet G., Behn-Krappa A., Devriendt K., Collen D., Conway S.J. and Carmeliet P. (2003). VEGF: a modifer of the del22q11 (DiGeorge) syndrome? Nat. Med. 9 (2), 173-182

9.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236

10.Devriendt K., Swillen A., Stalmans I. and Casteels I. (2005). Pulmonary atresia/ventricular septal defect associated with facial port-wine stain and retinal vascular abnormality: a new constellation or deletion in chromosome 22q11.2? Am. J. Med. Genet. A. 132 (3), 340-341

STALMANS Peter

1.Stalmans P. and Himpens B. (1997). Confocal imaging of Ca2+ signaling in cultured rat retinal pigment epithelial cells during mechanical and pharmacologic stimulation. Invest. Ophthalmol. Vis. Sci. 38 (1), 176-187

2.Stalmans P. and Himpens B. (1997). Effect of increasing glucose and protein phosphorylation on intercellular communication in cultured rat retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 38 (8), 1598-1609

3.Stalmans P., Leys A. and Van Limbergen E. (1997). External beam radiotherapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularisation in age-related macular degeneration: a review of 111 cases. Retina. 17 (6), 481-492

4.Stalmans P. and Himpens B. (1998). A decreased Ca2+-wave propagation is found among cultured RPE cells from dystrophic RCS rats. Invest. Ophthalmol. Vis. Sci. 39 (8), 1493-1502

5.D’Hollander F., Stalmans P., Van Libergen E. and Leys A. (1998). Retrospective study on the evolution of visual acuity after external beam radiotherapy (20 Gy, 2 Gy fractions) for subfoveal choroidal neovascular membranes in ARMD. Bull. Soc. belge Ophtalmol. 270, 27-34

6.Himpens B., Stalmans P., Gomez P., Malfait M. and Vereecke J. (1999). Intra- and intercellular Ca2+ signaling in retinal pigment epithelial cells during mechanical stimulation. FASEB J. 13 Suppl., S63-68

7.Stalmans P., Spileers W. and Dralands L. (1999). The use of optical coherence tomography in macular diseases. Bull. Soc. belge Ophtalmol. 272, 15-30

8.Stalmans P., Weckhuysen B., Schoonheydt R., Leys A., Missotten L., Spileers W. and Dralands L. (1999). How to protect your eyes from solar retinopathy. Bull. Soc. belge Ophtalmol. 272, 93-100

9.Stalmans P. and Himpens B. (1999). Properties of intra- and intercellular Ca(2+)-wave propagation elicited by mechanical stimulation in cultured RPE cells. Cell Calcium. 25 (6), 391-399

10.Spaide R.F., Leys A., Herrmann-Delemazure B., Stalmans P., Tittl M., Yannuzzi L.A., Burke K.M., Fisher Y.L., Freund K.B., Guyer D.R., Slakter J.S. and Sorenson J.A. (1999). Radiation-associated choroidal neovasculopathy. Ophthalmol. 106 (12), 2254-2260

11.Leys A., Stalmans P. and Blanckaert J. (2000). Sclerochoroidal calcification with choroidal neovascularisation. Arch. Ophthalmol. 118 (6), 854-857

12.Raus P., Stalmans P., Demeuter E., Spileers W. and Dralands L. (2001). Unusual retinal vasculitis in a patient with protein S deficiency and systemic toxoplasmosis: a case report. Bull. Soc. belge Ophtalmol. 279, 7-12

13.Stalmans P., Parys-Vanginderdeuren R., De Vos R. and Feron E.J. (2001). ICG staining of the inner limiting membrane facilitates its removal during surgery for macular holes and puckers. Bull. Soc. belge Ophtalmol. 281, 21-26

14.Feron E.J., Veckeneer M., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Stalmans P. (2002). Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch. Ophthalmol. 120 (2), 141-144

15.Stalmans P., Van Aken E.H., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285

16.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236

17.Stalmans P., Feron E.J., Parys-Van Ginderdeuren R., Van Lommel A., Melles G.R. and Veckeneer M. (2003). Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br. J. Ophthalmol. 87 (6), 713-716

18.Van de Moere A. and Stalmans P. (2003). Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage and silicone oil tamponade. Am. J. Ophthalmol. 136 (5), 879-887

19.Stalmans P., Van Lommel A. and Parys-Van Ginderdeuren R. (2003). Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathological correlation. Am. J. Ophthalmol. 136 (5), 961-962

20.Teba F.A., Mohr A., Eckardt C., Wong D., Kusaka S., Joondeph B.C., Feron E.J., Stalmans P., Van Overdam K. and Melles G.R. (2003). Trypan blue staining in vitreoretinal surgery. Ophthalmol. 110 (12), 2409-2412

21.van Meurs J.C., ter Averst E., Hofland L.J., van Hagen P.M., Mooy C.M., Baarsma G.S., Kuijpers R.W., Boks T. and Stalmans P. (2004). Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br. J. Ophthalmol. 88 (1), 110-113

22.Kolacny D., Parys-Vanginderdeuren R., Van Lommel A. and Stalmans P. (2005). Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema. Bull. Soc. belge Ophtalmol. 296, 15-23

STANESCU Dinu

1.De Potter P., Stanescu D., Caspers-Velu L. and Hofmans A. (2000). Photo essay: combined hamartoma of the retina and retinal pigment epithelium in Gorlin syndrome. Arch. Ophthalmol. 118 (7), 1004-1005

2.Stanescu D., Bodaghi B., Huong du L.T., Milea D., Goulet-Salmon B., Piette J.C., Le Hoang P. (2003). Pseudotumor cerebri associated with Sjogren’s syndrome. Graefes Arch. Clin. Exp. Ophthalmol. 241 (4), 339-342

3.Buono L.M., Foroozan R., Savino P.J., Danesh-Meyer H.V. and Stanescu D. (2003). Posterior ischemic optic neuropathy after hemodialysis. Ophthalmol. 110 (6), 1216-1218

4.Coscas F., Stanescu D., Coscas G. and Soubrane G. (2003). Feeder vessel treatment of choroidal neovascularisation in age-related macular degeneration (French). J. Fr. Ophthalmol. 26 (6), 602-608

5.Stanescu D., Wattenberg S. and Cohen S.Y. (2003). Photodynamic therapy for choroidal neovascularisation secondary to choroidal nervus. Am. J. Ophthalmol. 136 (3), 575-576

6.Tran T.H., Stanescu D., Caspers-Velu L., Rozenberg F., Liesnard C., Gaudric A., Le Hoang P. and Bodaghi B. (2004). Clinical characteristics of acute HSV-2 retinal necrosis (review). Am. J. Ophthalmol. 137 (5), 872-879

7.Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M. and Reme C. (2004). Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci. 24 (25), 5651-5658

8.Stanescu D. and Veriter C. (2005). A normal FEV1/VC ratio does not exclude airway obstruction. Respiration. 71 (4), 348-352

9.Diculescu M., Ciocarlan M., Ciocarlan M., Stanescu D., Ciprut T. and Marinescu T. (2005). Predictive factors for pseudocysts and peripancreatic collections in acute pancreatitis. Rom. J. Gastroenterol. 14 (2), 129-134

10.Stanescu D. and Pieters T. (2005). Anorexia nervosa and emphysema. Am. J. Respir. Crit. Care Med. 172 (3), 398-399

VAN AKEN Elisabeth

1.De Bleecker J.L., Meire V.I., Declercq W. and Van Aken E. (1999). Immunolocalisation of tumor necrosis factor-alpha and its receptors in inflammatory myopathies. Neuromuscul. Disord. 9 (4), 239-246

2.Van Hoorde L., Van Aken E. and Mareel M. (2000). Collagen type I: a substrate and a signal for invasion (review). Prog. Mol. Subcell. Biol. 25, 105-134

3.Van Aken E., Papeleu P., De Potter P., De Laey J.J. and Mareel M. (2000). Cadherin expression in the eye (review). Bull. Soc. belge Ophtalmol. 278, 55-59

4.Van Aken E., De Wever O., Correia da Rocha A.S. and Mareel M. (2001). Defective E-cadherin/catenin complexes in human cancer (review). Virchows Arch. 439 (6), 725-751

5.Van Aken E., Papeleu P., De Potter P., Bruyneel E., Philippe J., Seregard S., Kvanta A., De Laey J.J. and Mareel M.M. (2002). Structure and function of the N-cadherin/catenin complex in retinoblastoma. Invest. Ophthalmol. Vis. Sci. 43 (3), 595-602

6.Stalmans P., Van Aken E., Veckeneer M., Feron E.J. and Stalmans I. (2002). Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am. J. Ophthalmol. 134 (2), 282-285

7.Rodrigues S., Van Aken E., Van Bocxlaer S., Attoub S., Nguyen Q.D., Bruyneel E., Westley B.R., May F.M., Thim L., Mareel M., Gespach C. and Emami S. (2003). Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB J. 17 (1), 7-16

8.Van Aken E.H., De Wever O., Van Hoorde L., Bruyneel E., De Laey J.J. and Mareel M.M. (2003). Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor and focal adhesion kinase. Invest. Ophthalmol. Vis. Sci. 44 (2), 463-472

9.Stalmans P., Van Aken E.H., Melles G., Veckeneer M., Feron E.J. and Stalmans I. (2003). Trypan blue not toxic for retinal pigment epithelium in vitro. Am. J. Ophthalmol. 135 (2), 234-236

VAN TENTEN Yasmine

1.Tassignon M.J., De Groot V., Vervecken F. and Van Tenten Y. (1998). Secondary closure of posterior continuous curvilinear capsulorhexis in normal eyes and eyes at risk for postoperative inflammation. J. Cataract Refract. Surg. 24 (10), 1333-1338

2.Van Tenten Y., De Wolf A., Willekens B., Vrensen G.F. and Tassignon M.J. (1999). Temperature threshold for cell death of lens epithelial cells in a human capsular bag model. Exp. Eye Res. 69 (5), 569-574

3.Van Tenten Y., De Groot V., Wuyts F.L. and Tassignon M.J. (2000). Quantitative measurement of the PCCC area in the postoperative period. Br. J. Ophthalmol. 84 (10), 1117-1120

4.Van Tenten Y., Schuitmaker H.J., De Groot V., Willekens B., Vrensen G.F. and Tassignon M.J. (2000). Cell biological mechanisms underlying posterior capsule opacification: search for a therapy. Bull. Soc. belge. 278, 61-66

5.Van Tenten Y., Schuitmaker H.J., De Wolf A., Willekens B., Vrensen G.F. and Tassignon M.J. (2001). The effect of photodynamic therapy with bacteriochlorin A on lens epithelial cells in a capsular bag model. Exp. Eye Res. 72 (1), 41-48

6.Van Tenten Y., Schuitmaker H.J., De Groot V., Willekens B., Vrensen G.F. and Tassignon M.J. (2002). A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin A in rabbits. Ophthalmic Res. 34 (3), 113-118

7.De Groot V., Vrensen G.F., Willekens B., Van Tenten Y. and Tassignon M.J. (2003). In vitro study on the closure of posterior capsulorrhexis in the human eye. Invest. Ophthalmol. Vis. Sci. 44 (5), 2076-2083

WEYENBERG Wim

1.Weyenberg W. and Ludwig A. (2002). In vitro assessment of the interaction mechanisms between mucin and a cationic cellulosic derivative by rheological methods using an experimental design. Pharmazie. 57 (9), 628-631

2.Weyenberg W., Vermeire A., Remon J.P. and Ludwig A. (2003). Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. J. Control Release. 89 (2), 329-340

3.Hornof M., Weyenberg W., Ludwig A. and Bernkop-Schnurch A. (2003). Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J. Control Release. 89 (3), 419-428

4.Weyenberg W., Todorov V. and Ludwig A. (2004). Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design. Pharmazie. 59 (2), 121-125

5.Weyenberg W., Vermeire A., D’Haese E., Vanhaelewyn G., Kestelyn P., Callens F., Nelis H.J., Remon J.P. and Ludwig A. (2004). Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation. Eur. J. Pharm. Sci. 23 (1), 77-87

6.Weyenbergh W., Vermeire A., Dhondt M.M., Adriaens E., Kestelyn P., Remon J.P. and Ludwig A. (2004). Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Invest. Ophthalmol. Vis. Sci. 45 (9), 3229-3233

7.Dillen K., Weyenberg W., Vandervoort J. and Ludwig A. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur. J. Pharm. Biopharm. 58 (3), 539-549

8.Weyenberg W., Vermeire A., Vandervoort J., Remon J.P. and Ludwig A. (2005). Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets. Eur. J. Pharm. Biopharm. 59 (3), 527-536

9.Weyenberg W., Vermeire A., Remon J.P. and Ludwig A. (2005). Development and evaluation of sustained release ocular minitablets. J. Control Release. 101 (1-3), 371-374

10.Bozdag S., Weyenberg W. and Ludwig A. (2005). Rheological evaluation of dispersions, prepared with different non- and gamma-irradiated bioadhesive cospray dried powder mixtures. Pharmazie. 60 (8), 593-597

WILLERMAIN François

1.Willermain F., Caspers-Velu L., Baudson N., Dubois C., Hamdane M., Willems F., Velu T. and Bruyns C. (2000). Role and expression of CD40 on human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 (11), 3485-3491

2.Willermain F., Caspers-Velu L., Nowak B., Stordeur P., Mosselmans R., Salmon I., Velu T. and Bruyns C. (2002). Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br. J. Ophthalmol. 86 (12), 1417-1421

3.Willermain F., Greiner K. and Forrester J.V. (2002). Intensive immunosuppression treatment for central retinal vein occlusion in a young adult: a case report. Ocul. Immunol. Inflamm. 10 (2), 141-145

4.Cabay L., Willermain F., Bruyns C., Verdebout J.M., Witta Y., Baffi J., Velu T., Libert J., Caspers-Velu L., Maho A., Lespagnard L. (2003). CXCR4 expression in vitreoretinal membranes. Br. J. Ophthalmol. 87 (5), 567-569

5.Bali E., Willermain F., Caspers-Velu L., Dubois C., Dehou M.F., Velu T., Libert J. and Bruyns C. (2003). IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Int. J. Mol. Med. 12 (3), 305-310

6.Willermain F., Greiner K. and Forrester J.V. (2003). Atypical end-stage birdshot retinochoroidopathy. Ocul. Immunol. Inflamm. 11 (4), 305-307

7.Greiner K., Murphy C.C., Willermain F., Duncan L., Plskova J., Hale G., Isaacs J.D. and Dick A.D. (2004). Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Invest. Ophthalmol. Vis. Sci. 45 (1), 170-176